This article was exclusively written for The European Sting by Mr. Emad Mohamed, a 21-year-old third-year medical student at the University of Kordofan in Sudan. He is affiliated with the International Federation of Medical Students Associations (IFMSA), cordial partner of The Sting. The opinions expressed in this piece belong strictly to the writer and do not necessarily reflect IFMSA’s view on the topic, nor The European Sting’s one.

HIV/AIDS represents one of the major global health challenges, affecting millions of lives worldwide and having claimed 40.4 million lives [32.9-51.3 million] to date, with the virus continuing to spread in all countries. Some countries have reported increasing trends in new infections after witnessing a decline. Since the discovery of HIV in 1981, significant progress has been made in its treatment and prevention. However, gaps and challenges hinder its eradication. [1]

Early Days and Progress in Treatment

In the early years following the discovery of HIV/AIDS, the primary focus was on understanding the virus and method of infection. Currently, there is no treatment for HIV infection. However, the increasing availability of effective prevention, diagnosis, and symptomatic treatment, including antiretroviral therapy (ART), in the mid-1990s marked a significant milestone in transforming HIV from a fatal disease to a manageable chronic condition. Despite this breakthrough, access to these vital drugs was initially limited to high-income countries. [2]

Current Challenges in Treatment Access

Access to ART remains a significant challenge, particularly in developing countries. According to the World Health Organization (WHO), approximately 39.0 million people [33.1-45.7 million] worldwide are living with HIV, but only 27.4 million have access to ART. This is because of financial constraints, deteriorating healthcare infrastructure, and social and political barriers. [1] [2] [3]

Stigma and Discrimination

Stigma and discrimination against people living with HIV/AIDS remain significant barriers, preventing many from accessing testing and treatment. This stigma often leads to social isolation and weakens the impact of awareness and prevention programmes. To address these challenges, efforts should be focused on community education and engagement to create a supportive environment that fosters acceptance and provides psychological and social support. Promoting accurate information and combating misinformation are essential to ensure equitable access to effective healthcare for everyone. [3]

Gaps in Research and Development

Despite significant advancements in the treatment of HIV/AIDS, clear gaps in research and development have persisted. HIV is a DNA virus with a high ability to mutate, which poses a major challenge in creating an anti-viral vaccine or definitive cure. Current research focuses on developing long-acting injectable vaccines and improving the existing antiretroviral therapy (ART) regimens. [1] [4]

Role of International Organizations and Governments

Efforts to address the gaps in treatment and research require substantial financial support and strong international collaboration. International organizations and governments play a key role in supporting awareness programs and policies aimed at reducing the spread of disease. It is essential to strengthen healthcare laws and ensure the protection of healthcare workers and facilities in the conflict zones. Additionally, training healthcare professionals on safety protocols and providing logistical and psychological support are critical for the success of treatment and prevention strategies in these areas. [1] [5]

References

About the author

Emad Mohamed is a 21-year-old third-year medical student at the University of Kordofan in Sudan, with a keen interest in research, public health and a strong inclination toward applied education. He is passionate about learning and creative reading. He is actively involved in the International Federation of Medical Students’ Associations (IFMSA) through the MedSIN-Sudan club.